{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:45:54Z","timestamp":1794051954695,"version":"4.8.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.heliyon.2024.e24618","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T11:12:47Z","timestamp":1705057967000},"page":"e24618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Nephrotoxic drug burden and predictors of exposure among patients with renal impairment in Ethiopia: A multi-center study"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3528-0703","authenticated-orcid":false,"given":"Tirsit Ketsela","family":"Zeleke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1538-7757","authenticated-orcid":false,"given":"Leila Kenzu","family":"Kemal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eden Abetu","family":"Mehari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisel Dula","family":"Sema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulwase Mohammed","family":"Seid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizework Alemnew","family":"Mekonnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2560-2951","authenticated-orcid":false,"given":"Rahel Belete","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.heliyon.2024.e24618_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.burns.2009.08.012","article-title":"Acute kidney injury in critically ill burn patients. Risk factors, progression and impact on mortality","volume":"36","author":"Palmieri","year":"2010","journal-title":"Burns"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e24618_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.kisu.2017.07.003","article-title":"Reducing major risk factors for chronic kidney disease","volume":"7","author":"Luyckx","year":"2017","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.heliyon.2024.e24618_bib3","series-title":"Nephrotoxic Medications","author":"Patel","year":"2020"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e24618_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/japtr.JAPTR_336_18","article-title":"Nephrotoxicity: role and significance of renal biomarkers in the early detection of acute renal injury","volume":"10","author":"Al-Naimi","year":"2019","journal-title":"\\\"J. Adv. Pharm. Technol. Research\\\"\\\" (JAPTR)\\\""},{"key":"10.1016\/j.heliyon.2024.e24618_bib5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ki.2015.115","article-title":"Phenotype standardization for drug-induced kidney disease","volume":"88","author":"Mehta","year":"2015","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e24618_bib6","first-page":"743","article-title":"Drug-induced nephrotoxicity","volume":"78","author":"Naughton","year":"2008","journal-title":"Am. Fam. Physician"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e24618_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2174\/1389200218666171108154419","article-title":"Drug-induced nephrotoxicity: pathogenic mechanisms, biomarkers and prevention strategies","volume":"19","author":"Wu","year":"2018","journal-title":"Curr. Drug Metabol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e24618_bib8","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/pds.1962","article-title":"Analgesic use and the risk for progression of chronic kidney disease","volume":"19","author":"Kuo","year":"2010","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e24618_bib9","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1097\/CCM.0b013e318168e375","article-title":"An overview of drug-induced acute kidney injury","volume":"36","author":"Pannu","year":"2008","journal-title":"Crit. Care Med."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e24618_bib10","doi-asserted-by":"crossref","first-page":"959","DOI":"10.18553\/jmcp.2016.22.8.959","article-title":"Nephrotoxic medication exposure in US adults with predialysis chronic kidney disease: health services utilization and cost outcomes","volume":"22","author":"Davis-Ajami","year":"2016","journal-title":"Journal of Managed Care & Specialty Pharmacy"},{"key":"10.1016\/j.heliyon.2024.e24618_bib11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s00134-017-4773-5","article-title":"Understanding renal recovery","volume":"43","author":"Bell","year":"2017","journal-title":"Intensive Care Med."},{"issue":"suppl1_1","key":"10.1016\/j.heliyon.2024.e24618_bib12","first-page":"54","article-title":"Medicine prescribing practices in renally-impaired patients admitted to the internal medicine wards at Dr George Mukhari academic hospital, Ga-Rankuwa, South Africa","volume":"2017","author":"Mnukwa","year":"2017","journal-title":"African Journal for Physical Activity and Health Sciences (AJPHES)"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24618_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-015-0155-9","article-title":"Drug dosage adjustment in hospitalized patients with renal impairment at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia","volume":"16","author":"Getachew","year":"2015","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.heliyon.2024.e24618_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/8238250","article-title":"Medicine dose adjustment practice and associated factors among renally impaired patients in Amhara Regional State, Ethiopia","volume":"2021","author":"Zeleke","year":"2021","journal-title":"International Journal of Nephrology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e24618_bib15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jtumed.2015.02.012","article-title":"Contraindicated medications administered to inpatients with renal insufficiency in a Saudi Arabian hospital that has a computerized clinical decision support system","volume":"10","author":"Youssef","year":"2015","journal-title":"Journal of Taibah University Medical Sciences"},{"key":"10.1016\/j.heliyon.2024.e24618_bib16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s11096-019-00811-9","article-title":"The use of nephrotoxic drugs in patients with chronic kidney disease","volume":"41","author":"Okoro","year":"2019","journal-title":"Int. J. Clin. Pharm."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e24618_bib17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nrneph.2016.95","article-title":"Preventing acute kidney injury through nephrotoxin management","volume":"12","author":"Perazella","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e24618_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.12960","article-title":"Inappropriate prescribing in chronic kidney disease: a systematic review of prevalence, associated clinical outcomes and impact of interventions","volume":"71","author":"Tesfaye","year":"2017","journal-title":"Int. J. Clin. Pract."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e24618_bib19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7196\/SAMJ.6424","article-title":"Acute kidney injury risk factor recognition in three teaching hospitals in Ethiopia","volume":"103","author":"Phillips","year":"2013","journal-title":"S. Afr. Med. J."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24618_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12882-022-03053-6","article-title":"Mortality in hemodialysis patients in Ethiopia: a retrospective follow-up study in three centers","volume":"24","author":"Desta","year":"2023","journal-title":"BMC Nephrol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24618_bib21","first-page":"31","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e24618_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089072","article-title":"The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy","volume":"9","author":"Ingrasciotta","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24618_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12875-022-01931-4","article-title":"Appropriateness of drug prescriptions in patients with chronic kidney disease in primary care: a double-center retrospective study","volume":"23","author":"Ruiz-Boy","year":"2022","journal-title":"BMC Primary Care"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e24618_bib24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jphsr\/rmac020","article-title":"Pharmacist-driven renal dose optimization practice\u2014outcomes of a retrospective study in ambulatory care settings","volume":"13","author":"Parakkal","year":"2022","journal-title":"J. Pharmaceut. Health Serv. Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e24618_bib25","first-page":"361","article-title":"Principles for the prevention of medication-induced nephrotoxicity","volume":"34","author":"Rivera","year":"2022","journal-title":"Critical Care Nursing Clinics"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24618_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/imj.12291","article-title":"Dose adjustment guidelines for medications in patients with renal impairment: how consistent are drug information sources?","volume":"44","author":"Khanal","year":"2014","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.heliyon.2024.e24618_bib27","volume":"vol. 64","author":"Committee","year":"2012"},{"key":"10.1016\/j.heliyon.2024.e24618_bib28","series-title":"Dosing Guidelines for Adults","article-title":"Drug prescribing in renal failure","author":"Berns","year":"1999"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e24618_bib29","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/ckj\/sfab210","article-title":"Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care","volume":"15","author":"Bosi","year":"2022","journal-title":"Clinical Kidney Journal"},{"key":"10.1016\/j.heliyon.2024.e24618_bib30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s11096-014-0001-3","article-title":"Effectiveness of pharmacist intervention in patients with chronic kidney disease","volume":"36","author":"Cabello-Muriel","year":"2014","journal-title":"Int. J. Clin. Pharm."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e24618_bib31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijmedinf.2015.02.005","article-title":"A health record integrated clinical decision support system to support prescriptions of pharmaceutical drugs in patients with reduced renal function: design, development and proof of concept","volume":"84","author":"Shemeikka","year":"2015","journal-title":"Int. J. Med. Inf."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e24618_bib32","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.ajkd.2011.07.022","article-title":"Use of clinical decision support systems for kidney-related drug prescribing: a systematic review","volume":"58","author":"Tawadrous","year":"2011","journal-title":"Am. J. Kidney Dis."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e24618_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159335","article-title":"Chronic kidney disease, fluid overload and diuretics: a complicated triangle","volume":"11","author":"Khan","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24618_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1751-7176.2011.00564.x","article-title":"A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease","volume":"14","author":"Dussol","year":"2012","journal-title":"J. Clin. Hypertens."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e24618_bib35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jash.2012.07.004","article-title":"Thiazide diuretics in advanced chronic kidney disease","volume":"6","author":"Agarwal","year":"2012","journal-title":"Journal of the American Society of hypertension"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e24618_bib36","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1046\/j.1523-1755.2003.00273.x","article-title":"Role of excess volume in the pathophysiology of hypertension in chronic kidney disease","volume":"64","author":"Vasavada","year":"2003","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e24618_bib37","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ahj.2004.10.005","article-title":"Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure","volume":"148","author":"Tamirisa","year":"2004","journal-title":"Am. Heart J."},{"issue":"16","key":"10.1016\/j.heliyon.2024.e24618_bib38","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.ehj.2004.06.003","article-title":"Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease: the Task Force on ACE-inhibitors of the European Society of Cardiology","volume":"25","author":"Lopez-Sendon","year":"2004","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.heliyon.2024.e24618_bib39","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00392-008-0668-3","article-title":"RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection","volume":"97","author":"Werner","year":"2008","journal-title":"Clin. Res. Cardiol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e24618_bib40","article-title":"Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension","author":"Li","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.heliyon.2024.e24618_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01507837","article-title":"Nephrotoxicity of ACE-inhibitors: age and chronic renal failure increase the risk","volume":"5","author":"Boiskin","year":"1995","journal-title":"Geriatr. Nephrol. Urol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24618_bib42","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/qjmed\/77.1.1013","article-title":"Renovascular disease and renal complications of angiotensin-converting enzyme inhibitor therapy","volume":"77","author":"Kalra","year":"1990","journal-title":"QJM: an international journal of medicine"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e24618_bib43","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/pds.1641","article-title":"Exposure of the elderly to potential nephrotoxic drug combinations in Belgium","volume":"17","author":"Smets","year":"2008","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e24618_bib44","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-100-3-352","article-title":"Risk factors for nephrotoxicity in patients treated with aminoglycosides","volume":"100","author":"Moore","year":"1984","journal-title":"Annals of internal medicine"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e24618_bib45","doi-asserted-by":"crossref","first-page":"E475","DOI":"10.1503\/cmaj.121730","article-title":"Risk of acute kidney injury associated with the use of fluoroquinolones","volume":"185","author":"Bird","year":"2013","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24618_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/j.ackd.2019.08.001","article-title":"Nephrotoxicity of antimicrobials and antibiotics","volume":"27","author":"Morales-Alvarez","year":"2020","journal-title":"Adv. Chron. Kidney Dis."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e24618_bib47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/1753-0407.12113","article-title":"Metformin nephrotoxicity insights: will they change clinical management?","volume":"6","author":"Thomas","year":"2013","journal-title":"J. Diabetes"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e24618_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229344","article-title":"Omeprazole use and risk of chronic kidney disease evolution","volume":"15","author":"Guedes","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e24618_bib49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/jgs.15682","article-title":"High\u2010risk comorbidity combinations in older patients undergoing emergency general surgery","volume":"67","author":"Ho","year":"2019","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.heliyon.2024.e24618_bib50","first-page":"419","article-title":"Ageing and the glomerular filtration rate: truths and consequences","volume":"120","author":"Glassock","year":"2009","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e24618_bib51","first-page":"70","article-title":"Clinical analysis of etiology, risk factors and outcome in patients with acute kidney injury","volume":"27","author":"Hamzic-Mehmedbasic","year":"2015","journal-title":"Mater. Soc. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e24618_bib52","first-page":"403","article-title":"Medication prescribing patterns among chronic kidney disease patients in a hospital in Malaysia","volume":"23","author":"Al-Ramahi","year":"2012","journal-title":"Saudi Journal of Kidney Diseases and Transplantation"},{"key":"10.1016\/j.heliyon.2024.e24618_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2023.154292","article-title":"Drug-related causes attributed to acute kidney injury and their documentation in intensive care patients","author":"Murphy","year":"2023","journal-title":"J. Crit. Care"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e24618_bib54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJMra032401","article-title":"Acute renal failure and sepsis","volume":"351","author":"Schrier","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e24618_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2458-13-350","article-title":"Chronic kidney disease in Nicaragua: a qualitative analysis of semi-structured interviews with physicians and pharmacists","volume":"13","author":"Ramirez-Rubio","year":"2013","journal-title":"BMC Publ. Health"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e24618_bib56","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1517\/14740338.2014.951328","article-title":"Safety of ACE inhibitor therapies in patients with chronic kidney disease","volume":"13","author":"Sidorenkov","year":"2014","journal-title":"Expet Opin. Drug Saf."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e24618_bib57","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/intqhc\/mzg046","article-title":"Medication misuse in hospitalized patients with renal impairment","volume":"15","author":"Salomon","year":"2003","journal-title":"Int. J. Qual. Health Care"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024006492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024006492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:22:03Z","timestamp":1783930923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024006492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2405844024006492"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24618","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nephrotoxic drug burden and predictors of exposure among patients with renal impairment in Ethiopia: A multi-center study","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e24618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e24618"}}